Crescent Biopharma, Inc.CBIONASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+69.4%
5Y CAGR+25.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+69.4%/yr
vs -8.3%/yr prior
5Y CAGR
+25.2%/yr
Recent acceleration
Acceleration
+77.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $138.09M | +146.0% |
| 2024 | $56.14M | +179.7% |
| 2023 | $20.07M | -29.3% |
| 2022 | $28.39M | -40.2% |
| 2021 | $47.49M | +5.7% |
| 2020 | $44.93M | -4.5% |
| 2019 | $47.03M | +17.3% |
| 2018 | $40.09M | +66.4% |
| 2017 | $24.10M | +3.5% |
| 2016 | $23.28M | - |